Sano GeneticsBiopharma1 / 13Read in the app

Pitch deck

Sano Genetics's pitch deck

The deck, and the 4 rounds we watched Sano Genetics raise afterwards, with the investors each report named.

Sano Genetics is a biotechnology and software company based in Cambridge, UK, founded in 2017. The company focuses on advancing precision medicine by connecting patients with genetic data to relevant research studies. Its mission is to create the largest ethical source of genomic and biomedical data to support personalized medicine. Sano operates a comprehensive platform that streamlines the entire lifecycle of precision medicine research. This includes patient recruitment for clinical trials, at-home DNA testing, and tools for long-term participant engagement. The platform also offers biomarker screening and analytics, ensuring data privacy and transparency for participants. Sano serves both research partners, such as pharmaceutical and biotech companies, and individual participants interested in contributing their genetic data to scientific research.

13 slides2.5MBGBBiopharma

Read the deckFree account. The deck belongs to Sano Genetics, so reading it needs one; everything on this page is public.

What is in it

The deck, slide by slide

Each slide by what it argues. 13 slides against a median of 13 across the 1,712 decks we hold.

median
  1. 1Cover
  2. 2
  3. 3Business model
  4. 4Vision
  5. 5Product
  6. 6Market
  7. 7Product
  8. 8Financials
  9. 9Product
  10. 10Business model
  11. 11Product
  12. 12The ask
  13. 13Contact

CoverBusiness modelVisionProductMarketFinancialsThe askContact

  1. Feb 2026

    Round$3.6M

    No investor was named in the report.

    Source recorded

  2. Jul 2024
  3. Sept 2023

    Round$11M

    No investor was named in the report.

    Source recorded

  4. Feb 2022

    Round$11M

    No investor was named in the report.

    Source recorded

Everyone who backed Sano Genetics

Sano Genetics pitch deck, cover slide1 / 13

The deck itself

Read Sano Genetics's full pitch deck

All 13 slides, each read for what it argues and set against the decks that raised at the same stage. The cover is shown here; the rest is read in the app.

Read the deck →Free account. The deck belongs to Sano Genetics.

Investors who claim them

Firms listing Sano Genetics on their own portfolio page: the firm's own account rather than a round we watched. Weaker than an announcement, much stronger than a list somebody sold us.

More decks

Browse all 1,712 decks. We hold no record of where this file came from or on what terms. If it is yours and you would rather it were not here, tell us and it goes.